Home › Funds › ACUTA CAPITAL PARTNERS, LLC › ORIC
ACUTA CAPITAL PARTNERS, LLC position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 87,918 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.93% of its reported portfolio and ranking #27 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed ORIC holdings in 3 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's ORIC position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in ORIC in Q1 2024 at 103,992 shares (US$1.4M). Across 3 filings, ACUTA CAPITAL PARTNERS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 87,918 shares valued at US$1.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 103.99K | $1.43M | New |
| Q2 2024 | 96.00K | $678.72K | Reduce |
| Q3 2026 | 87.92K | $1.18M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), AIHC Capital Management Ltd (US$62.4M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- AIHC Capital Management Ltd 4.63M sh · $62.38M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- Siren, L.L.C. 3.36M sh · $45.23M · Q3 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- EcoR1 Capital, LLC 3.03M sh · $40.79M · Q3 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- First Turn Management, LLC 1.57M sh · $21.21M · Q3 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Paradigm Biocapital Advisors LP 1.51M sh · $20.28M · Q3 2026
- Integral Health Asset Management, LLC 1.70M sh · $20.20M · Q3 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held ORIC?
ACUTA CAPITAL PARTNERS, LLC has disclosed ORIC holdings in 3 of the last 11 reported quarters, going back to Q1 2024.
What is ACUTA CAPITAL PARTNERS, LLC's current position in ORIC?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 87.92K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $1.18M, representing 0.93% of its reported portfolio and ranking #27.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling ORIC?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in ORIC.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., AIHC Capital Management Ltd, SR ONE CAPITAL MANAGEMENT, LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.